For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...
(Scott Olson/Getty Images) In the final days of the Biden administration, the Foodand DrugAdministration proposed ... including the FDA and the Centers for Disease Control and Prevention ...
The Bridgewater, N.J., biopharmaceutical company said brensocatib has the potential to become the first and only approved treatment for non-cystic fibrosis bronchiectasis, which causes the lungs' ...